At this complex time for the market, PharmaNutra is strengthening its investment plan with the launch of a new campaign. […]
The Group communicates that it has signed new agreements with Casa Marzam S.A. and with Zentiva K.S. to distribute its […]
The Group’s senior management presented its results and new development prospects to the financial community, which met for the Italian […]
The food supplement market is growing in Italy and SiderAL® Forte 20 capsules is the most sold nutritional supplement in […]
Publication of the start of coverage survey drafted by Mediobanca; declaring a target price at €24.50. PharmaNutra S.p.A. has […]
The Group obtains approval of two new patents for the Sucrosomial® Technology and signs a distribution agreement for the SiderAL® […]
Yesterday in London, the key event focusing on Italian companies in the AIM segment. BUY rating with increased target price […]
The financial performance of the Group have been consolidated thanks to the scientific achievements of the technology Sucrosomial®, the constant […]
Expansion continues on the Asian markets for the range containing Sucrosomial® Iron. From January to September an impressive 9 new […]
PharmaNutra S.p.A. signs a new agreement for the distibution of the SiderAL® line in Taiwan. HONG CHI Biotech will be the […]
Around 400,000 units sold in July A new historical record for PharmaNutra S.p.A.: for the first time, in […]
The Group’s growth trend is confirmed and it announces the purchase of the building that will hold its first own […]